← Back to search results

AwardedFind a Tender · award

PromethION 24 Sequencing Unit PRO-SEQ024 and Consumables

Buyer: THE UNIVERSITY OF BIRMINGHAM →

BuyerTHE UNIVERSITY OF BIRMINGHAM
StatusAwarded
DeadlineNot published
ValueValue not published
Published26 Sept 2023

What is being bought

Genomics Birmingham at the University of Birmingham is home to a diverse range of cutting-edge technologies dedicated to supporting the research endeavours of University of Birmingham (UoB) scholars and students. Our service laboratories, situated on Level 2 of the Institute of Biomedical Research (IBR) within the College of Medical and Dental Sciences (MDS), offer an array of resources and expertise. One pivotal component of our service offerings is the utilization of Oxford Nanopore Technology sequencing platforms. These platforms distinguish themselves significantly from other sequencing technologies available within our service portfolio. Oxford Nanopore Technology stands out due to its unparalleled capacity to produce data outputs that are beyond the reach of any other sequencing technology, whether it is within our genomics service or external providers. We are currently equipped with the PromethION, MinION, and GridION platforms, allowing us to harness the full potential of this groundbreaking technology to benefit the research community at Genomics Birmingham.

Delivery location

UKG

Categories

Laboratory, optical and precision equipments (excl. glasses) 38000000

Lot details

Lot 1

Our decision to source Oxford Nanopore Technologies for these sequencing platforms is founded on several irrefutable factors. Oxford Nanopore Technologies not only manufactures the instruments but also produces the necessary consumables, establishing them as the sole comprehensive source for our requirements. Moreover, the proprietary nature of their technology is affirmed by a series of patents, including WO2010/086622, WO2012/164270, WO2013/014451, WO2014/013260, WO2013/041878, WO2010/000789, US5795782A1, US6015714A1, US6362002B1, US7189503B2, EP0815438B1, EP1238275B1, and US8673556B2. We already have these sequencers in the laboratory and cannot purchase the required consumables for the equipment from any other provider. Oxford Nanopore are the sole providers of consumables and reagents for their sequencers. This unique position of Oxford Nanopore Technologies as both manufacturer and patent holder translates into our sole reliance on them to provide not only the hardware and software components but also the indispensable consumables essential for the operation of these sequencing platforms. Their proprietary knowledge and technical expertise extend to servicing the equipment and offering invaluable guidance on resolving technical challenges, making them the unrivalled choice for our genomics service. No other company possesses the capability to furnish us with the complete suite of resources and support necessary to uphold the exceptional standards of research and innovation we strive to maintain at Genomics Birmingham. Oxford Nanopore Technologies (ONT) holds a unique position in the genomics and sequencing industry for several reasons, which sets them apart from other companies and makes them the preferred choice for Genomics Birmingham: Proprietary Technology: ONT's sequencing technology is proprietary and patented, as indicated by the list of patents provided. This means that they have exclusive rights to this innovative technology, giving them a competitive advantage. Other companies may use different sequencing technologies that may not offer the same advantages or capabilities. Unique properties of Oxford Nanopore sequencing technologies are as follows: • Benchtop instrument that can sequence native DNA from fragment sizes of 20bp to millions of bases for up to 24 independent samples gaining coverage of >30X per sample. • Sequencing of native DNA and native RNA to give output files of modified BAMs and FASTQ files for 5mC and 5hmC methylation and canonical bases. This is performed in one sequencing run simultaneously with no need for additional manipulation of the DNA or RNA. • Real-time sequencing, with real-time basecalling & alignment enabling • Sequencing until a defined coverage is met and/or the ability to fix a run time for your sequencing requirements without the need for a default run time. • Adaptive sampling (enrichment or depletion of known regions without any need for PCR or chemical pull down) this is also capable dynamically allowing targets where read depth is already met to stop sequencing so other targets can be covered. • The same libraries can be run on all Oxford Nanopore instruments, for example, to perform library QC or generate additional data • Possibility to perform a sequencing run, recover the library from the flow cell, and re-sequence to boost yield. Also the ability to wash and re-load the same flow cell enabling flexibility and maximum usage. These properties are unique to Oxford Nanopore and not available from other providers. Data Output: ONT's sequencing platforms, such as the PromethION, MinION, and GridION, are known for their ability to produce unique and extensive data outputs that can be critical for various research applications. The data quality and quantity achieved through ONT's technology may not be matched by alternatives. The duplex chemistry provides around Q30 (99.9%) accuracy with the detection of modified bases at no extra cost or manipulation. Fragments of any size from 20bp upwards can be analysed in the same sequencing run, in real time. Adaptive sampling provides enrichment or depletion without the need for any other manipulation of the DNA or RNA. The P24 can run 24 flow cells independently of each other allowing for maximum flexibility.

What is included

ItemCategoryQuantity
1Not publishedNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 38. The category anchor is Laboratory, optical and precision equipments (excl. glasses) (38000000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 382,9922 median · 12 average (1,388 of 2,992 with a bid count)2.6 average (1,588 of 2,992 with named award suppliers)Not published
Same buyer151 median · 1.8 average (9 of 15 with a bid count)1 average (11 of 15 with named award suppliers)Not published
Delivery region: UKG633 median · 36 average (23 of 63 with a bid count)2.9 average (27 of 63 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleOur decision to source Oxford Nanopore Technologies for these sequencing platforms is founded on several irrefutable factors. Oxford Nanopore Technologies not only manufactures the instruments but also produces the necessary consumables, establishing them as the sole comprehensive source for our requirements. Moreover, the proprietary nature of their technology is affirmed by a series of patents, including WO2010/086622, WO2012/164270, WO2013/014451, WO2014/013260, WO2013/041878, WO2010/000789, US5795782A1, US6015714A1, US6362002B1, US7189503B2, EP0815438B1, EP1238275B1, and US8673556B2. We already have these sequencers in the laboratory and cannot purchase the required consumables for the equipment from any other provider. Oxford Nanopore are the sole providers of consumables and reagents for their sequencers.
Rationale classificationsThe procurement falls outside the scope of application of the directive
Special regimeNot published
Covered byGPA
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0

No planning milestones published.

Related procurements

No linked framework, prior procurement or reprocurement published.

Awards

Contracts

PromethION 24 Sequencing Unit PRO-SEQ024 and Consumables

Statusactive
Value£202,518

Documents & submission route

No documents are published in the current source record.

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-0403c5
Latest release ID028333-2023
Latest release timestampTue Sep 26 2023 10:57:53 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statuscomplete
Procurement methodlimited
Procurement method detailsAward procedure without prior publication of a call for competition
Main procurement categorygoods
Above thresholdNot published
Legal basis32014L0024
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender valueNot published
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release1
Contracts in latest release1
Parties in latest release3

Notice history

DateEventReference
26 Sept 2023award, contract028333-2023

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "028333-2023",
  "tag": [
    "award",
    "contract"
  ],
  "date": "2023-09-26T11:57:53+01:00",
  "ocid": "ocds-h6vhtk-0403c5",
  "buyer": {
    "id": "GB-COH-RC000645",
    "name": "THE UNIVERSITY OF BIRMINGHAM"
  },
  "awards": [
    {
      "id": "028333-2023-SC12009/23-1",
      "title": "PromethION 24 Sequencing Unit PRO-SEQ024 and Consumables",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-05386273",
          "name": "Oxford Nanopore Technologies plc"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "SC12009/23",
    "lots": [
      {
        "id": "1",
        "hasOptions": false,
        "description": "Our decision to source Oxford Nanopore Technologies for these sequencing platforms is founded on several irrefutable factors. Oxford Nanopore Technologies not only manufactures the instruments but also produces the necessary consumables, establishing them as the sole comprehensive source for our requirements. Moreover, the proprietary nature of their technology is affirmed by a series of patents, including WO2010/086622, WO2012/164270, WO2013/014451, WO2014/013260, WO2013/041878, WO2010/000789, US5795782A1, US6015714A1, US6362002B1, US7189503B2, EP0815438B1, EP1238275B1, and US8673556B2. We already have these sequencers in the laboratory and cannot purchase the required consumables for the equipment from any other provider. Oxford Nanopore are the sole providers of consumables and reagents for their sequencers. \nThis unique position of Oxford Nanopore Technologies as both manufacturer and patent holder translates into our sole reliance on them to provide not only the hardware and software components but also the indispensable consumables essential for the operation of these sequencing platforms. Their proprietary knowledge and technical expertise extend to servicing the equipment and offering invaluable guidance on resolving technical challenges, making them the unrivalled choice for our genomics service. No other company possesses the capability to furnish us with the complete suite of resources and support necessary to uphold the exceptional standards of research and innovation we strive to maintain at Genomics Birmingham. \nOxford Nanopore Technologies (ONT) holds a unique position in the genomics and sequencing industry for several reasons, which sets them apart from other companies and makes them the preferred choice for Genomics Birmingham: \nProprietary Technology: ONT's sequencing technology is proprietary and patented, as indicated by the list of patents provided. This means that they have exclusive rights to this innovative technology, giving them a competitive advantage. Other companies may use different sequencing technologies that may not offer the same advantages or capabilities. \nUnique properties of Oxford Nanopore sequencing technologies are as follows:  \n• Benchtop instrument that can sequence native DNA from fragment sizes of 20bp to millions of bases for up to 24 independent samples gaining coverage of >30X per sample.  \n• Sequencing of native DNA and native RNA to give output files of modified BAMs and FASTQ files for 5mC and 5hmC methylation and canonical bases. This is performed in one sequencing run simultaneously with no need for additional manipulation of the DNA or RNA. \n• Real-time sequencing, with real-time basecalling & alignment enabling  \n• Sequencing until a defined coverage is met and/or the ability to fix a run time for your sequencing requirements without the need for a default run time.  \n• Adaptive sampling (enrichment or depletion of known regions without any need for PCR or chemical pull down) this is also capable dynamically allowing targets where read depth is already met to stop sequencing so other targets can be covered. \n• The same libraries can be run on all Oxford Nanopore instruments, for example, to perform library QC or generate additional data  \n• Possibility to perform a sequencing run, recover the library from the flow cell, and re-sequence to boost yield. Also the ability to wash and re-load the same flow cell enabling flexibility and maximum usage. \nThese properties are unique to Oxford Nanopore and not available from other providers. \nData Output: ONT's sequencing platforms, such as the PromethION, MinION, and GridION, are known for their ability to produce unique and extensive data outputs that can be critical for various research applications. The data quality and quantity achieved through ONT's technology may not be matched by alternatives.\nThe duplex chemistry provides around Q30 (99.9%) accuracy with the detection of modified bases at no extra cost or manipulation. Fragments of any size from 20bp upwards can be analysed in the same sequencing run, in real time. Adaptive sampling provides enrichment or depletion without the need for any other manipulation of the DNA or RNA. The P24 can run 24 flow cells independently of each other allowing for maximum flexibility."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKG"
          }
        ]
      }
    ],
    "title": "PromethION 24 Sequencing Unit PRO-SEQ024 and Consumables",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "Genomics Birmingham at the University of Birmingham is home to a diverse range of cutting-edge technologies dedicated to supporting the research endeavours of University of Birmingham (UoB) scholars and students. Our service laboratories, situated on Level 2 of the Institute of Biomedical Research (IBR) within the College of Medical and Dental Sciences (MDS), offer an array of resources and expertise. \nOne pivotal component of our service offerings is the utilization of Oxford Nanopore Technology sequencing platforms. These platforms distinguish themselves significantly from other sequencing technologies available within our service portfolio. Oxford Nanopore Technology stands out due to its unparalleled capacity to produce data outputs that are beyond the reach of any other sequencing technology, whether it is within our genomics service or external providers. We are currently equipped with the PromethION, MinION, and GridION platforms, allowing us to harness the full potential of this groundbreaking technology to benefit the research community at Genomics Birmingham.",
    "classification": {
      "id": "38000000",
      "scheme": "CPV",
      "description": "Laboratory, optical and precision equipments (excl. glasses)"
    },
    "procurementMethod": "limited",
    "mainProcurementCategory": "goods",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "Our decision to source Oxford Nanopore Technologies for these sequencing platforms is founded on several irrefutable factors. Oxford Nanopore Technologies not only manufactures the instruments but also produces the necessary consumables, establishing them as the sole comprehensive source for our requirements. Moreover, the proprietary nature of their technology is affirmed by a series of patents, including WO2010/086622, WO2012/164270, WO2013/014451, WO2014/013260, WO2013/041878, WO2010/000789, US5795782A1, US6015714A1, US6362002B1, US7189503B2, EP0815438B1, EP1238275B1, and US8673556B2. We already have these sequencers in the laboratory and cannot purchase the required consumables for the equipment from any other provider. Oxford Nanopore are the sole providers of consumables and reagents for their sequencers.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
        "description": "The procurement falls outside the scope of application of the directive"
      }
    ]
  },
  "parties": [
    {
      "id": "GB-COH-RC000645",
      "name": "THE UNIVERSITY OF BIRMINGHAM",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKG31",
        "locality": "BIRMINGHAM",
        "postalCode": "B152TT",
        "countryName": "United Kingdom",
        "streetAddress": "Edgbaston"
      },
      "details": {
        "url": "https://www.birmingham.ac.uk/index.aspx",
        "buyerProfile": "https://www.birmingham.ac.uk/index.aspx",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "09",
            "scheme": "COFOG",
            "description": "Education"
          }
        ]
      },
      "identifier": {
        "id": "RC000645",
        "scheme": "GB-COH",
        "legalName": "THE UNIVERSITY OF BIRMINGHAM"
      },
      "contactPoint": {
        "name": "Kseniya Samsonik",
        "email": "K.Samsonik@bham.ac.uk",
        "telephone": "+44 1214146899"
      }
    },
    {
      "id": "GB-COH-05386273",
      "name": "Oxford Nanopore Technologies plc",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Oxford",
        "postalCode": "OX4 4DQ",
        "countryName": "United Kingdom",
        "streetAddress": "Gosling Building Edmund Halley Road, Oxford Science Park,"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "id": "05386273",
        "scheme": "GB-COH",
        "legalName": "Oxford Nanopore Technologies plc"
      }
    },
    {
      "id": "GB-FTS-8446",
      "name": "The University of Birmingham",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Birmingham",
        "postalCode": "B15 2TT",
        "countryName": "United Kingdom"
      },
      "identifier": {
        "legalName": "The University of Birmingham"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "028333-2023-SC12009/23-1",
      "title": "PromethION 24 Sequencing Unit PRO-SEQ024 and Consumables",
      "value": {
        "amount": 202518,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "028333-2023-SC12009/23-1",
      "dateSigned": "2023-09-26T00:00:00+01:00"
    }
  ],
  "initiationType": "tender"
}
Complete JSON history (1 releases)
26 Sept 2023 · 028333-2023 · award, contract
{
  "id": "028333-2023",
  "tag": [
    "award",
    "contract"
  ],
  "date": "2023-09-26T11:57:53+01:00",
  "ocid": "ocds-h6vhtk-0403c5",
  "buyer": {
    "id": "GB-COH-RC000645",
    "name": "THE UNIVERSITY OF BIRMINGHAM"
  },
  "awards": [
    {
      "id": "028333-2023-SC12009/23-1",
      "title": "PromethION 24 Sequencing Unit PRO-SEQ024 and Consumables",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-COH-05386273",
          "name": "Oxford Nanopore Technologies plc"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "SC12009/23",
    "lots": [
      {
        "id": "1",
        "hasOptions": false,
        "description": "Our decision to source Oxford Nanopore Technologies for these sequencing platforms is founded on several irrefutable factors. Oxford Nanopore Technologies not only manufactures the instruments but also produces the necessary consumables, establishing them as the sole comprehensive source for our requirements. Moreover, the proprietary nature of their technology is affirmed by a series of patents, including WO2010/086622, WO2012/164270, WO2013/014451, WO2014/013260, WO2013/041878, WO2010/000789, US5795782A1, US6015714A1, US6362002B1, US7189503B2, EP0815438B1, EP1238275B1, and US8673556B2. We already have these sequencers in the laboratory and cannot purchase the required consumables for the equipment from any other provider. Oxford Nanopore are the sole providers of consumables and reagents for their sequencers. \nThis unique position of Oxford Nanopore Technologies as both manufacturer and patent holder translates into our sole reliance on them to provide not only the hardware and software components but also the indispensable consumables essential for the operation of these sequencing platforms. Their proprietary knowledge and technical expertise extend to servicing the equipment and offering invaluable guidance on resolving technical challenges, making them the unrivalled choice for our genomics service. No other company possesses the capability to furnish us with the complete suite of resources and support necessary to uphold the exceptional standards of research and innovation we strive to maintain at Genomics Birmingham. \nOxford Nanopore Technologies (ONT) holds a unique position in the genomics and sequencing industry for several reasons, which sets them apart from other companies and makes them the preferred choice for Genomics Birmingham: \nProprietary Technology: ONT's sequencing technology is proprietary and patented, as indicated by the list of patents provided. This means that they have exclusive rights to this innovative technology, giving them a competitive advantage. Other companies may use different sequencing technologies that may not offer the same advantages or capabilities. \nUnique properties of Oxford Nanopore sequencing technologies are as follows:  \n• Benchtop instrument that can sequence native DNA from fragment sizes of 20bp to millions of bases for up to 24 independent samples gaining coverage of >30X per sample.  \n• Sequencing of native DNA and native RNA to give output files of modified BAMs and FASTQ files for 5mC and 5hmC methylation and canonical bases. This is performed in one sequencing run simultaneously with no need for additional manipulation of the DNA or RNA. \n• Real-time sequencing, with real-time basecalling & alignment enabling  \n• Sequencing until a defined coverage is met and/or the ability to fix a run time for your sequencing requirements without the need for a default run time.  \n• Adaptive sampling (enrichment or depletion of known regions without any need for PCR or chemical pull down) this is also capable dynamically allowing targets where read depth is already met to stop sequencing so other targets can be covered. \n• The same libraries can be run on all Oxford Nanopore instruments, for example, to perform library QC or generate additional data  \n• Possibility to perform a sequencing run, recover the library from the flow cell, and re-sequence to boost yield. Also the ability to wash and re-load the same flow cell enabling flexibility and maximum usage. \nThese properties are unique to Oxford Nanopore and not available from other providers. \nData Output: ONT's sequencing platforms, such as the PromethION, MinION, and GridION, are known for their ability to produce unique and extensive data outputs that can be critical for various research applications. The data quality and quantity achieved through ONT's technology may not be matched by alternatives.\nThe duplex chemistry provides around Q30 (99.9%) accuracy with the detection of modified bases at no extra cost or manipulation. Fragments of any size from 20bp upwards can be analysed in the same sequencing run, in real time. Adaptive sampling provides enrichment or depletion without the need for any other manipulation of the DNA or RNA. The P24 can run 24 flow cells independently of each other allowing for maximum flexibility."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKG"
          }
        ]
      }
    ],
    "title": "PromethION 24 Sequencing Unit PRO-SEQ024 and Consumables",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "Genomics Birmingham at the University of Birmingham is home to a diverse range of cutting-edge technologies dedicated to supporting the research endeavours of University of Birmingham (UoB) scholars and students. Our service laboratories, situated on Level 2 of the Institute of Biomedical Research (IBR) within the College of Medical and Dental Sciences (MDS), offer an array of resources and expertise. \nOne pivotal component of our service offerings is the utilization of Oxford Nanopore Technology sequencing platforms. These platforms distinguish themselves significantly from other sequencing technologies available within our service portfolio. Oxford Nanopore Technology stands out due to its unparalleled capacity to produce data outputs that are beyond the reach of any other sequencing technology, whether it is within our genomics service or external providers. We are currently equipped with the PromethION, MinION, and GridION platforms, allowing us to harness the full potential of this groundbreaking technology to benefit the research community at Genomics Birmingham.",
    "classification": {
      "id": "38000000",
      "scheme": "CPV",
      "description": "Laboratory, optical and precision equipments (excl. glasses)"
    },
    "procurementMethod": "limited",
    "mainProcurementCategory": "goods",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "Our decision to source Oxford Nanopore Technologies for these sequencing platforms is founded on several irrefutable factors. Oxford Nanopore Technologies not only manufactures the instruments but also produces the necessary consumables, establishing them as the sole comprehensive source for our requirements. Moreover, the proprietary nature of their technology is affirmed by a series of patents, including WO2010/086622, WO2012/164270, WO2013/014451, WO2014/013260, WO2013/041878, WO2010/000789, US5795782A1, US6015714A1, US6362002B1, US7189503B2, EP0815438B1, EP1238275B1, and US8673556B2. We already have these sequencers in the laboratory and cannot purchase the required consumables for the equipment from any other provider. Oxford Nanopore are the sole providers of consumables and reagents for their sequencers.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
        "description": "The procurement falls outside the scope of application of the directive"
      }
    ]
  },
  "parties": [
    {
      "id": "GB-COH-RC000645",
      "name": "THE UNIVERSITY OF BIRMINGHAM",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKG31",
        "locality": "BIRMINGHAM",
        "postalCode": "B152TT",
        "countryName": "United Kingdom",
        "streetAddress": "Edgbaston"
      },
      "details": {
        "url": "https://www.birmingham.ac.uk/index.aspx",
        "buyerProfile": "https://www.birmingham.ac.uk/index.aspx",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "09",
            "scheme": "COFOG",
            "description": "Education"
          }
        ]
      },
      "identifier": {
        "id": "RC000645",
        "scheme": "GB-COH",
        "legalName": "THE UNIVERSITY OF BIRMINGHAM"
      },
      "contactPoint": {
        "name": "Kseniya Samsonik",
        "email": "K.Samsonik@bham.ac.uk",
        "telephone": "+44 1214146899"
      }
    },
    {
      "id": "GB-COH-05386273",
      "name": "Oxford Nanopore Technologies plc",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UK",
        "locality": "Oxford",
        "postalCode": "OX4 4DQ",
        "countryName": "United Kingdom",
        "streetAddress": "Gosling Building Edmund Halley Road, Oxford Science Park,"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "id": "05386273",
        "scheme": "GB-COH",
        "legalName": "Oxford Nanopore Technologies plc"
      }
    },
    {
      "id": "GB-FTS-8446",
      "name": "The University of Birmingham",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Birmingham",
        "postalCode": "B15 2TT",
        "countryName": "United Kingdom"
      },
      "identifier": {
        "legalName": "The University of Birmingham"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "028333-2023-SC12009/23-1",
      "title": "PromethION 24 Sequencing Unit PRO-SEQ024 and Consumables",
      "value": {
        "amount": 202518,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "028333-2023-SC12009/23-1",
      "dateSigned": "2023-09-26T00:00:00+01:00"
    }
  ],
  "initiationType": "tender"
}